The ELISA results illustrate the robust induction of IL-1β, IL-18 and HMGB1 production, an indicator of pyroptosis-induced ICD, in both tumor and serum samples following treatment with GSDMBNT mRNA@LNPs alone or in combination with a-PD1 (Fig. 5c). This evidence concerns the gene IL18 and neoplasm.